Clinical Trial Update: SGLT2 Inhibition and Left Ventricular Mass [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on SGLT2 inhibition and left ventricular mass in type 2 diabetes, currently terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hannover Medical School | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: TERMINATED